The Psychological Impact on Parents of Children who Receive an Inconclusive Diagnosis for Cystic Fibrosis following Newborn Screening: A Systematic Mini-Review

Newborn screening (NBS) has been available for the diagnosis of cystic fibrosis (CF) over the last decades. Through the implementation of NBS, a new designation emerged, that of CF related metabolic syndrome (CRMS) or cystic fibrosis screen positive inconclusive diagnosis (CFSPID). As there is uncertainty regarding the clinical progression of these infants to CF, some studies have investigated the psychological impact of CRMS/CFSPID on their parents. This systematic narrative review aimed to describe the findings of the relevant studies. The number of studies is limited and the study samples are relatively small. It seems that there is a negative impact of CRMS/CFSPID on parental mental health. While some studies indicated similar levels of parental anxiety among those with infants diagnosed with CF and those with CRMS/CFSPID, not all studies reached the same conclusion. Parental uncertainty represents another mental dimension of the impact associated with the designation of CRMS/CFSPID. These observations suggest that parents of infants with CRMS/CFSPID should be provided with effective communication, and it may also be beneficial to consider parental mental screening. More robust and long-term studies are required to detect differences in parental emotional status between those with infants diagnosed with CF and those with CRMS/CFSPID.

[1]  M. Moustaki,et al.  Children with cystic fibrosis are still receiving inconclusive diagnosis despite undergoing newborn screening , 2023, Acta paediatrica.

[2]  A. Tosco,et al.  A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening , 2023, Children.

[3]  T. Keens,et al.  High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results. , 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[4]  S. Kirsa,et al.  Depression and anxiety prevalence in people with cystic fibrosis and their caregivers: a systematic review and meta-analysis , 2022, Social Psychiatry and Psychiatric Epidemiology.

[5]  R. Macleod,et al.  Receiving results of uncertain clinical relevance from population genetic screening: systematic review & meta-synthesis of qualitative research , 2022, European Journal of Human Genetics.

[6]  O. Sommerburg,et al.  Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID). , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[7]  K. Southern,et al.  Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: A Qualitative Study , 2019, International journal of neonatal screening.

[8]  Roger L. Brown,et al.  Impact of Intermediate Cystic Fibrosis Classification on Parents’ Perceptions of Child Vulnerability and Protectiveness , 2019, Journal of family nursing.

[9]  Carolyn J. Barg,et al.  Psychosocial Response to Uncertain Newborn Screening Results for Cystic Fibrosis , 2017, The Journal of pediatrics.

[10]  O. Sommerburg,et al.  The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[11]  A. Munck,et al.  Cystic Fibrosis Transmembrane Conductance Regulator‐Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis , 2017, The Journal of pediatrics.

[12]  E. Leray,et al.  Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up. , 2010, The Journal of pediatrics.

[13]  A. Tluczek,et al.  When the Cystic Fibrosis Label Does Not Fit: A Modified Uncertainty Theory , 2010, Qualitative health research.

[14]  C. Castellani,et al.  Inconclusive Cystic Fibrosis neonatal screening results: long‐term psychosocial effects on parents , 2009, Acta paediatrica.

[15]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.

[16]  Rachel Grob.  Is my sick child healthy? Is my healthy child sick?: changing parental experiences of cystic fibrosis in the age of expanded newborn screening. , 2008, Social science & medicine.

[17]  M. Rosenfeld,et al.  Guidelines for Implementation of Cystic Fibrosis Newborn Screening Programs: Cystic Fibrosis Foundation Workshop Report , 2007, Pediatrics.

[18]  L. Curnow,et al.  Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening , 2006, Journal of paediatrics and child health.

[19]  P M Farrell,et al.  Cystic Fibrosis Newborn Screening: Impact on Reproductive Behavior and Implications for Genetic Counseling , 1998, Pediatrics.

[20]  P. Farrell,et al.  Parents' Knowledge of Neonatal Screening and Response to False‐Positive Cystic Fibrosis Testing , 1992, Journal of developmental and behavioral pediatrics : JDBP.